Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Neil Hayes

Showing results (121-130 of 171) with videos related to

Pageof 18
Sort By:
Cancer Research Communications|March 6, 2026
The KRAS-variant and cetuximab in HPV-positive oropharyngeal cancer - results from the NRG/RTOG 1016 trialJoanne B Weidhaas, Jonathan Harris, Maura L Gillison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2019
Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal CancerBhishamjit S Chera, Sunil Kumar, Brian T Beaty, et al.
Cancer Research Communications|September 23, 2022
Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck CancerRyan M Murphy, Jason Tasoulas, Alessandro Porrello, et al.
Head and Neck Pathology|July 24, 2023
HN-CLEAR: Head and Neck Consensus Language for Ease and Reproducibility, a Multidisciplinary Consensus Mechanism for Head and Neck PathologyRuta Gupta, Munita Bal, Justin A Bishop, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2020
Concurrent Definitive Immunoradiotherapy for Patients with Stage III-IV Head and Neck Cancer and Cisplatin ContraindicationJared Weiss, Siddharth Sheth, Allison M Deal, et al.
Elife|July 1, 2022
Response to immune checkpoint blockade improved in pre-clinical model of breast cancer after bariatric surgeryLaura M Sipe, Mehdi Chaib, Emily B Korba, et al.
Plos One|June 16, 2015
Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLCXiaobei Zhao, Anyou Wang, Vonn Walter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2022
A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and NeckCherie-Ann O Nathan, D Neil Hayes, Theodore Karrison, et al.
Cell Reports|June 23, 2021
Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancerAjeeth K Pingili, Mehdi Chaib, Laura M Sipe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarraysKevin K Dobbin, David G Beer, Matthew Meyerson, et al.
Pageof 18

Showing results (121-130 of 171) with videos related to

Sort By:
Pageof 18
Cancer Research Communications|March 6, 2026
The KRAS-variant and cetuximab in HPV-positive oropharyngeal cancer - results from the NRG/RTOG 1016 trialJoanne B Weidhaas, Jonathan Harris, Maura L Gillison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 16, 2019
Rapid Clearance Profile of Plasma Circulating Tumor HPV Type 16 DNA during Chemoradiotherapy Correlates with Disease Control in HPV-Associated Oropharyngeal CancerBhishamjit S Chera, Sunil Kumar, Brian T Beaty, et al.
Cancer Research Communications|September 23, 2022
Tumor Cell Extrinsic Synaptogyrin 3 Expression as a Diagnostic and Prognostic Biomarker in Head and Neck CancerRyan M Murphy, Jason Tasoulas, Alessandro Porrello, et al.
Head and Neck Pathology|July 24, 2023
HN-CLEAR: Head and Neck Consensus Language for Ease and Reproducibility, a Multidisciplinary Consensus Mechanism for Head and Neck PathologyRuta Gupta, Munita Bal, Justin A Bishop, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 7, 2020
Concurrent Definitive Immunoradiotherapy for Patients with Stage III-IV Head and Neck Cancer and Cisplatin ContraindicationJared Weiss, Siddharth Sheth, Allison M Deal, et al.
Elife|July 1, 2022
Response to immune checkpoint blockade improved in pre-clinical model of breast cancer after bariatric surgeryLaura M Sipe, Mehdi Chaib, Emily B Korba, et al.
Plos One|June 16, 2015
Combined Targeted DNA Sequencing in Non-Small Cell Lung Cancer (NSCLC) Using UNCseq and NGScopy, and RNA Sequencing Using UNCqeR for the Detection of Genetic Aberrations in NSCLCXiaobei Zhao, Anyou Wang, Vonn Walter, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 4, 2022
A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and NeckCherie-Ann O Nathan, D Neil Hayes, Theodore Karrison, et al.
Cell Reports|June 23, 2021
Immune checkpoint blockade reprograms systemic immune landscape and tumor microenvironment in obesity-associated breast cancerAjeeth K Pingili, Mehdi Chaib, Laura M Sipe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2005
Interlaboratory comparability study of cancer gene expression analysis using oligonucleotide microarraysKevin K Dobbin, David G Beer, Matthew Meyerson, et al.
Pageof 18